Back to Medicine Index

Oseflu 75 mg

Capsule

Generic: Oseltamivir

Beximco Pharmaceuticals Ltd.

Therapeutic Class: Antiviral (Neuraminidase Inhibitor)

Indications

Treatment of influenza A and B when started within 48 hours of the first symptoms. Prevention of influenza after exposure.

Pharmacology

Oseltamivir is a prodrug converted to oseltamivir carboxylate, which inhibits influenza virus neuraminidase. This prevents release of new virus particles from infected cells and limits the spread of infection.

Dosage & Administration

Treatment, adult and child over 40 kg: 75 mg twice daily for 5 days. Prevention: 75 mg once daily for 10 days. Child 1-12 years, twice daily for 5 days: up to 15 kg 30 mg; 15-23 kg 45 mg; 23-40 kg 60 mg. Reduce the dose in renal impairment.

Side Effects

Nausea, vomiting, abdominal pain, headache. Rarely: skin reactions, neuropsychiatric events (confusion, abnormal behaviour), particularly in children and adolescents.

Precautions & Warnings

Taking it with food reduces nausea. It is not a substitute for influenza vaccination. Watch children and adolescents for unusual behaviour. Adjust the dose in renal impairment. Use as directed by a registered physician and complete the advised course.

Contraindications

Hypersensitivity to oseltamivir.

Storage Conditions

Store below 30°C in a cool, dry place, away from light. Keep out of the reach of children.

This information is for reference only. Always consult a qualified doctor or pharmacist before taking any medicine.